CellfreeSystemfortheexaminationofapoptoticactivity

發布時間：2019-04-27 17:04 原文鏈接： CellfreeSystemfortheexaminationofapoptoticactivity

Introduction
In our lab we use the term 'cell-free system' when we talk about the examination of apoptotic activity in cytoplasmic extracts. The cytoplasmic extracts may be prepared from cells which were treated in culture with an apoptosis-inducing agent or from untreated cells. In the latter case, apoptotic activity can be induced by addition of apoptotic stimuli (such as recombinant active caspases or cytochrome c) to the extracts. Apoptotic activity in the cytoplasmic extracts can be examined by the measurement of enzymatic caspase-acticity, by western blots of proteins processed during apoptosis (caspases and their substrates), or by using isolated cell nuclei as indicators for apoptotic factors inducing nuclear morphological changes and/or DNA fragmentation. It was in 1993 when the first paper described that a cell-free system can mimic characteristic features of apoptosis in intact cells (Lazebnik et al., 1993, J. Cell Biol., 123(1): 7-22). Indeed, it has become clear that the apoptotic pathways acting in the cytoplasm function independently from the nucleus and thus, cell-free systems appear to be appropriate model systems which represent at least part of the apoptotic machinery and signaling mechanisms. Cell-free systems have been previously successfully applied in the dissection of biochemical mechanisms during the apoptotic process, such as the identification and characterization of the 'apoptosome', AIF, and the DNA fragmentation factor ICAD (Zou et al., 1997, Cell, 90:405-413; Susin et al., 1999, Nature, 397: 441-446; Enari et al., 1998, Nature, 391: 43-50). Also signaling pathways such as the caspase-cascade have been studied under cell-free conditions, poviding insight into activation patterns and inhibitor-specificities (Mesner et al., 1999, JBC, 274 22635-22645; Faleiro et al., 1997, EMBO, 16(9): 2271-2281; Takahashi et al., 1997, Oncogene, 14: 2741-2752). The protocols described below are derived essentially from Lazebnik et al., 1993, J. Cell Biol., 123(1): 7-22 and Fearnhead et al., 1997, Genes and Dev., 11: 126-1276.

Activation of apoptotic activity in cytoplasmic extracts and measurement of the resulting caspase enzymatic acticity

Activation reaction
Cytoplasmic extracts were activated according to following protocol (as an example, cytochrome c/dATP are used as apoptotic stimuli). The components were mixed in the given order and then incubated at 37°C usually for 45 min.
x μl Dilution Buffer (DB) containing ATP regeneration system +
1.5 μl cytochrome c from bovine heart (50 μM) +
1.5 μl dATP (10 mM)+
y μl cytoplasmic extract (37.5 μg protein)
x was so adjusted that the total volume was 15 μl and thus the final protein concentration at 2.5 μg/μl.
When active recombinant caspases (such as caspase-8) are used for activation of the extracts, 100 ng of recombinant caspase is added instead of cytoc/dATP.
In case that the effect of inhibitors was studied, such as Ac-DEVD-fmk, or zVAD-fmk, the inhibitor at concentrations ranging from 100 nM up to 100 μM was preincubated together with the extract in DB for 5 min, then cyto c/dATP was added.
Caspase enzymatic assay
After incubation of the extracts in the presence or absence of activating stimuli (cytochrome c/dATP or active recombinant caspase), caspase enzymatic activity was measured according to following protocol:
200 μl of Caspase Assay Buffer (CAB) containing 20 μM fluorescent substrate (Ac-DEVD-amc Ac-YVAD-amc, Ac-VEID-amc; Calbiochem) was added to the activation reaction. The samples were transfered into the wells of a 96 flat-bottom well plate. After incubation in the dark for 30 min at RT, fluorescence was measured at 360/460 nm with a FL500 fluorimeter (Bio-Tek). If a standard-curve of various concentrations (0 up to 5 μM in CAB) of aminomethylcoumarin (amc) is measured, the enzyme activity can be calculated and expressed as pikomoles of substrate (amc) hydrolyzed per microgram of protein (in the extract) per minute [pmol ? μg^-1 ? min^-1] or just as change of the amc concentration in nanomolar per microgam of protein [nM ? μg^-1].

Activation of apoptotic activity in cytoplasmic extracts for western blot analysis

Activation reaction
Cytoplasmic extracts were activated according to following protocol (as an example, cytochrome c/dATP are used as apoptotic stimuli). The components were mixed in the given order and then incubated at 37°C usually for 1 h.
x μl Dilution Buffer (DB) containing ATP regeneration system +
0.46 μl cytochrome c from bovine heart (325 μM) +
0.3 μl dATP (100 mM)+
y μl cytoplasmic extract (75 μg protein)
x was so adjusted that the total volume was 30 μl and thus the final protein concentration at 2.5 μg/μl.
When active recombinant caspases (such as caspase-8) are used for activation of the extracts, 100 ng of recombinant caspase is added instead of cytoc/dATP.
In case that the effect of inhibitors was studied, such as Ac-DEVD-fmk, or zVAD-fmk, the inhibitor at concentrations ranging from 100 nM up to 100 μM was preincubated together with the extract in DB for 5 min, then cyto c/dATP was added.
Western Blot Analysis
After incubation of the extracts in the presence or absence of activating stimuli (cytochrome c/dATP or active recombinant caspase), western blots were performed loading usually 20 μg protein in sample buffer per lane on a 4-20% SDS-PAGE gel.

Reconstitution of activated cytoplasmic extracts with isolated nuclei. Analysis of apoptotic activity by qualitative DNA laddering assay and DAPI staining.

Reaction mix
Cytoplasmic extracts were diluted with DB to a concentration of 7.5 μg protein per ml in a total volume of 50 μl. The extracts were activated or not activated by addition of e.g. 10 μM cytochrome c and 1 mM dATP, then 300,000 isolated nuclei in a volume of 1.5 μl NSB (e.g. from Jurkat cells) were added. The reactions were incubated at 37°C for 4 h.
Here is an example for a reaction mix for this kind of experiment:

y corresponds to 375 μg protein, and x is calculated so that the final volume is 50 μl.
After incubation, the nuclei were either analyzed by DNA laddering or DAPI staining or both, as described below.

Pipet x μl of DB into a microfuge tube.
Add 1.5 μl of cytochrome c (325 μM) and 0.5 μl of dATP (100 mM) to reaction mix.
Then pipet y μl of cytoplasmic extract into the tubes.
Add 1 μl of nuclei in NSB (2x10⁸ nuclei / ml).
Incubate for 4h at 37°C.

DAPI staining of nuclei from cell-free system

Pipet 10 μl of 4% paraformaldehyde solution (in PBS) onto a glass slide.
Add 3 μl of the cell-free reaction mix to the fixing solution on slide.
Cover with glass cover and seal cover-slide border with e.g. nail paint to prevent drying.
Observe nuclei under fluorescence microscope at 350 nm (UV filter).
Count at least 150 nuclei and determine apoptotic or normal morphological phenotype.

DNA laddering assay with nuclei from cell-free system

Add 400 μl of Lysis Buffer (containing 0.5 μg/ml proteinase K, freshly added) to the cell-free reaction.
Incubate over night at 37°C.
Add 40 μl of 3M NaOAc, pH8.0, mix.
Add 900 μl of ice-cold 100% ethanol, mix.
Spin precipitated DNA down at 16,000xg at 4°C for 20 min.
Dry DNA pellet at the air or in speed vac.
Add 20 μl of TE buffer containing 0.2 mg/ml RNase A.
Incubate at 37°C for at least 30 min.
Add 5 μl sample buffer (5x).
Load samples onto a 1.5% agarose gel, run at about 4V per cm for about 2h.

Reconstitution of activated cytoplasmic extracts with isolated radioactive nuclei. Analysis of apoptotic activity by quantitative, radioactive DNA fragmentation assays or DAPI staining.

Radioactive DNA fragmentation assay

Radioactive nuclei (e.g from ALVA31 cells) were prepared as described in the protocol "Isolation of cell nuclei for the application in a cell-free system". Prior to use in the cell-free system, 5x10⁴ nuclei in NSB (5 μl of 10⁷ nuclei per ml) were distributed in 0.5 ml microfuge tubes and were washed once in 50 μl DB. The nuclei were then incubated in cytoplasmic extracts (final protein concentration 7.5 mg/ml) in the presence or absence of 10 μM cyt c and 1 mM dATP in a total volume of 10 μl for 4 h at 37°C (650 nuclei/μg protein).

Here is an example for a reaction mix for this kind of experiment:

Pipet 5x10⁴ radioactive nuclei in NSB (= 5 μl of a stock with 10⁷ nuclei per ml) into 0.5 ml microfuge tubes. Add 50 μl of DB. Mix. Spin nuclei down at 800 x g (at 4 degrees celsius) and carefully remove supernatant.
Add x μl of DB to the nuclei.
Add 0.3 μl of cytochrome c (325 μM) and 1 μl of dATP (10 mM) to reaction mix.
then y μl of cytoplasmic extract.
Incubate for 4h at 37°C.

y corresponds to 75 μg protein, and x is calculated so that the final volume is 10 μl.

After incubation, the nuclei were transferred from the microfuge tubes into the wells of a 96 well plate; the nuclei's DNA was harvested on a glassfiber membrane and the retented radioactivity measured by scintillation counting. Experiments were run in triplicate or pentuplicate for each condition. The percentage of DNA fragmentation was calculated as follows:

( [cpm of nuclei in pure extracts] - [cpm of nuclei in extracts + cyto c/dATP] ) / [cpm of nuclei in pure extracts] x 100

MATERIAL
Extract Dilution Buffer (DB):
COMPOSITION:	RECIPE for 500 μl:
10 mM HEPES (pH 7.0) 5 mM EGTA 50 mM NaCl 2 mM MgCl2 1 mM DTT supplemented with ATP regeneration system: 2 mM ATP 10 mM phosphocreatine 50 μg/ml creatine kinase	100 μl of 50 mM HEPES, pH 7.0 incl. 25 mM EGTA 25 μl of 1 M KCl 10 μl of 100 mM MgCl2 0.5 μl of 1 M DTT - 5 μl of 200 mM ATP in water 10 μl of 500 mM phosphocreatine in water 10 μl of 2.5 mg/ml creatine kinase in KPM buffer 365 μl H₂O nuclease free

Add DTT and ATP regeneration system always fresh to the buffer, just before use!

Caspase Assay Buffer (CAB):
COMPOSITION:	RECIPE for 50 ml:
50 mM PIPES 0.1 mM EDTA 10% glycerol 1 mM DTT	838.4 mg PIPES 10 μl of 0.5 M EDTA 5 ml glycerol -

add 40 ml H₂O, adjust pH=7.2 using KOH (about 200 μl of 1M KOH), then fill up to the final volume of 50 ml.

1mM DTT is always added fresh to the buffer, just before use.

Lysis Buffer (for DNA isolation from nuclei)
COMPOSITION:	RECIPE for 50 ml:
50 mM Tris-HCl, pH 8.0 10 mM EDTA 0.2 % SDS	5 ml of 0.5 M Tris-HCl, pH 8.2 1 ml of 0.5 M EDTA, pH 8.0 1 ml 10% SDS add 43 ml H₂O

before use, add proteinase K to a concentration of 0.5 mg/ml

TE Buffer
COMPOSITION:	RECIPE for 50 ml:
50 mM Tris-HCl, pH 8.0 1 mM EDTA	5 ml of 0.5 M Tris-HCl, pH 8.2 100 μl of 0.5 M EDTA, pH 8.0 add 44.9 ml H₂O

4% Paraformaldehyde in PBS
RECIPE for 100 ml:
Heat 80 ml H₂O to 60°C under stirring add 4g Paraformaldehyde cover, let stir at 60°C, but do not overheat add 2 drops of 1 N NaOH: solution becomes almost clear, but contains some particles that will not dissolve add 4 ml of 25x PBS adjust pH to 7.0 with HCl bring to final volume with H₂O filter solution and store in brown glass bottle at 4°C Solution is good for at least 1 year. Work under a hood!!!

其他網友還關注過

Cell-free System for the examination of apoptotic activity
Preparation of cytoplasmic extracts for the application inacell-free system
Preparation of cytoplasmic extracts forthe application in acell-free system
Isolation of cell nuclei for the application in the cell-free system
Methods for the Measurement of a Bacterial Enzyme Activity in Cell Lysates3
Methods for the Measurement of a Bacterial Enzyme Activity in Cell Lysates
Methods for the Measurement of a Bacterial Enzyme Activity in Cell Lysates4
Examination of a Mammalian Blood Smear
Glycolysis Pathway
FAS signaling pathway ( CD95 )

CellfreeSystemfortheexaminationofapoptoticactivity

其他網友還關注過

中國期刊“黑神話”，比肩NCS！影響因子高達33.2

助力提升實驗室效率，安捷倫推出全新高級稀釋系統

SCIEX臨床質譜新品重磅上市|Citrine?TripleQuad?System

190億！賽默飛收購歐洲IVD巨頭

施普林格·自然與TheLens達成合作

“3CoinONE全新體驗氣袋進樣器”ANTOP獎進入專家評審階段

青源峰達太赫茲在國際頂級期刊《TrendsinBiotechnology》發文

科學家將人工智能技術成功用于蛋白質復合物結構預測

發力癌癥分子病理診斷，無錫臻和全資收購TissueofOrigin?

這3個雜志撤回中國學者249篇文章，包含上交、中山等名校